HEADER HORMONE/GROWTH FACTOR RECEPTOR 07-DEC-99 1DKF TITLE CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND- TITLE 2 BINDING DOMAINS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (RETINOID X RECEPTOR-ALPHA); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: RXR-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PROTEIN (RETINOIC ACID RECEPTOR-ALPHA); COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 12 SYNONYM: RAR-ALPHA; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS HELICAL SANDWICH, HETERODIMER, PROTEIN-LIGAND COMPLEX, HORMONE/GROWTH KEYWDS 2 FACTOR RECEPTOR, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL KEYWDS 3 GENOMICS, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.BOURGUET,V.VIVAT,J.M.WURTZ,P.CHAMBON,H.GRONEMEYER,D.MORAS, AUTHOR 2 STRUCTURAL PROTEOMICS IN EUROPE (SPINE) REVDAT 8 07-FEB-24 1DKF 1 REMARK REVDAT 7 03-NOV-21 1DKF 1 REMARK SEQADV REVDAT 6 11-APR-18 1DKF 1 REMARK REVDAT 5 04-APR-18 1DKF 1 REMARK REVDAT 4 04-OCT-17 1DKF 1 REMARK REVDAT 3 24-FEB-09 1DKF 1 VERSN REVDAT 2 26-APR-00 1DKF 1 REMARK SEQRES SEQADV REVDAT 1 19-APR-00 1DKF 0 JRNL AUTH W.BOURGUET,V.VIVAT,J.M.WURTZ,P.CHAMBON,H.GRONEMEYER,D.MORAS JRNL TITL CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR JRNL TITL 2 LIGAND-BINDING DOMAINS. JRNL REF MOL.CELL V. 5 289 2000 JRNL REFN ISSN 1097-2765 JRNL PMID 10882070 JRNL DOI 10.1016/S1097-2765(00)80424-4 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26091 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1286 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 157 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.180 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DKF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-99. REMARK 100 THE DEPOSITION ID IS D_1000010158. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-97 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SOFTWARE AT SYNCHROTRON REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29168 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.20400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 10000, PH 7.25 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.26667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 138.53333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 103.90000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 173.16667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.63333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.26667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 138.53333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 173.16667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 103.90000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 34.63333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 250 REMARK 465 THR A 251 REMARK 465 GLU A 252 REMARK 465 THR A 253 REMARK 465 TYR A 254 REMARK 465 VAL A 255 REMARK 465 GLU A 256 REMARK 465 ALA A 257 REMARK 465 ASN A 258 REMARK 465 MET A 259 REMARK 465 GLY A 260 REMARK 465 LEU A 261 REMARK 465 ASN A 262 REMARK 465 PRO A 263 REMARK 465 SER A 264 REMARK 465 SER A 265 REMARK 465 ASN B 211 REMARK 465 ASN B 212 REMARK 465 SER B 213 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN B 416 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 236 106.06 -57.80 REMARK 500 PRO A 292 127.06 -29.02 REMARK 500 HIS A 293 -8.20 68.76 REMARK 500 VAL A 325 174.78 -50.69 REMARK 500 LEU A 358 -78.46 -119.00 REMARK 500 LEU A 425 -0.33 -57.77 REMARK 500 ILE A 447 50.85 34.25 REMARK 500 ASP A 449 -2.81 59.88 REMARK 500 PHE B 199 97.72 -160.59 REMARK 500 THR B 251 32.49 -78.78 REMARK 500 GLN B 344 74.18 -117.34 REMARK 500 MET B 379 1.86 -66.48 REMARK 500 MET B 406 74.46 68.95 REMARK 500 LEU B 409 -22.71 -161.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMS B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA A 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LBD RELATED DB: PDB REMARK 900 1LBD CONTAINS THE UNLIGANDED RXR LIGAND-BINDING DOMAIN REMARK 900 RELATED ID: 2LBD RELATED DB: PDB REMARK 900 2LBD CONTAINS THE RAR-GAMMA LIGAND-BINDING DOMAIN BOUND TO ALL- REMARK 900 TRANS RETINOIC ACID REMARK 900 RELATED ID: IGBMC-0012-000 RELATED DB: TARGETDB DBREF 1DKF A 230 462 UNP P28700 RXRA_MOUSE 230 462 DBREF 1DKF B 182 416 UNP P10276 RARA_HUMAN 182 416 SEQADV 1DKF ALA A 318 UNP P28700 PHE 318 ENGINEERED MUTATION SEQRES 1 A 233 SER ALA ASN GLU ASP MET PRO VAL GLU LYS ILE LEU GLU SEQRES 2 A 233 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 A 233 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 A 233 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 A 233 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 A 233 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 A 233 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER ALA SER HIS SEQRES 8 A 233 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 A 233 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 A 233 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 A 233 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 A 233 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 A 233 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 A 233 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 A 233 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 A 233 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 A 233 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 A 233 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA SEQRES 1 B 235 PRO GLU VAL GLY GLU LEU ILE GLU LYS VAL ARG LYS ALA SEQRES 2 B 235 HIS GLN GLU THR PHE PRO ALA LEU CYS GLN LEU GLY LYS SEQRES 3 B 235 TYR THR THR ASN ASN SER SER GLU GLN ARG VAL SER LEU SEQRES 4 B 235 ASP ILE ASP LEU TRP ASP LYS PHE SER GLU LEU SER THR SEQRES 5 B 235 LYS CYS ILE ILE LYS THR VAL GLU PHE ALA LYS GLN LEU SEQRES 6 B 235 PRO GLY PHE THR THR LEU THR ILE ALA ASP GLN ILE THR SEQRES 7 B 235 LEU LEU LYS ALA ALA CYS LEU ASP ILE LEU ILE LEU ARG SEQRES 8 B 235 ILE CYS THR ARG TYR THR PRO GLU GLN ASP THR MET THR SEQRES 9 B 235 PHE SER ASP GLY LEU THR LEU ASN ARG THR GLN MET HIS SEQRES 10 B 235 ASN ALA GLY PHE GLY PRO LEU THR ASP LEU VAL PHE ALA SEQRES 11 B 235 PHE ALA ASN GLN LEU LEU PRO LEU GLU MET ASP ASP ALA SEQRES 12 B 235 GLU THR GLY LEU LEU SER ALA ILE CYS LEU ILE CYS GLY SEQRES 13 B 235 ASP ARG GLN ASP LEU GLU GLN PRO ASP ARG VAL ASP MET SEQRES 14 B 235 LEU GLN GLU PRO LEU LEU GLU ALA LEU LYS VAL TYR VAL SEQRES 15 B 235 ARG LYS ARG ARG PRO SER ARG PRO HIS MET PHE PRO LYS SEQRES 16 B 235 MET LEU MET LYS ILE THR ASP LEU ARG SER ILE SER ALA SEQRES 17 B 235 LYS GLY ALA GLU ARG VAL ILE THR LEU LYS MET GLU ILE SEQRES 18 B 235 PRO GLY SER MET PRO PRO LEU ILE GLN GLU MET LEU GLU SEQRES 19 B 235 ASN HET OLA A 700 20 HET BMS B 600 34 HETNAM OLA OLEIC ACID HETNAM BMS 4-[(4,4-DIMETHYL-1,2,3,4-TETRAHYDRO-[1, HETNAM 2 BMS 2']BINAPTHALENYL-7-CARBONYL)-AMINO]-BENZOIC ACID FORMUL 3 OLA C18 H34 O2 FORMUL 4 BMS C29 H26 N2 O3 FORMUL 5 HOH *157(H2 O) HELIX 1 1 SER A 230 MET A 235 1 6 HELIX 2 2 PRO A 236 VAL A 247 1 12 HELIX 3 3 ASP A 268 THR A 283 1 16 HELIX 4 4 THR A 283 ARG A 290 1 8 HELIX 5 5 PRO A 298 SER A 322 1 25 HELIX 6 6 ARG A 339 ALA A 345 1 7 HELIX 7 7 VAL A 347 LEU A 358 1 12 HELIX 8 8 LEU A 358 MET A 365 1 8 HELIX 9 9 ASP A 368 PHE A 381 1 14 HELIX 10 10 ASN A 390 TYR A 413 1 24 HELIX 11 11 GLY A 418 LEU A 425 1 8 HELIX 12 12 LEU A 425 GLU A 439 1 15 HELIX 13 13 LEU A 446 THR A 450 5 5 HELIX 14 14 PRO A 451 ALA A 462 1 12 HELIX 15 15 PRO B 182 PHE B 199 1 18 HELIX 16 16 ALA B 201 LEU B 205 5 5 HELIX 17 17 ASP B 221 LEU B 246 1 26 HELIX 18 18 THR B 253 THR B 275 1 23 HELIX 19 19 ARG B 294 GLY B 301 1 8 HELIX 20 20 PHE B 302 PRO B 304 5 3 HELIX 21 21 LEU B 305 LEU B 316 1 12 HELIX 22 22 LEU B 317 GLU B 320 5 4 HELIX 23 23 ASP B 322 ILE B 335 1 14 HELIX 24 24 GLN B 344 ARG B 367 1 24 HELIX 25 25 HIS B 372 MET B 379 1 8 HELIX 26 26 MET B 379 ILE B 402 1 24 HELIX 27 27 LEU B 409 ASN B 416 1 8 SHEET 1 A 2 GLY A 328 LEU A 330 0 SHEET 2 A 2 HIS A 336 HIS A 338 -1 N VAL A 337 O ILE A 329 SHEET 1 B 3 TYR B 277 THR B 278 0 SHEET 2 B 3 THR B 283 THR B 285 -1 O THR B 283 N THR B 278 SHEET 3 B 3 THR B 291 ASN B 293 -1 O LEU B 292 N MET B 284 SITE 1 AC1 18 HOH B 33 PHE B 199 PHE B 228 SER B 229 SITE 2 AC1 18 LEU B 231 SER B 232 THR B 233 CYS B 235 SITE 3 AC1 18 ILE B 236 LEU B 269 ILE B 270 ILE B 273 SITE 4 AC1 18 ARG B 276 PHE B 286 SER B 287 PHE B 302 SITE 5 AC1 18 GLY B 391 MET B 406 SITE 1 AC2 11 HOH A 9 ALA A 276 ALA A 277 GLN A 280 SITE 2 AC2 11 ASN A 311 ALA A 318 ARG A 321 LEU A 331 SITE 3 AC2 11 ALA A 332 CYS A 437 PHE A 444 CRYST1 116.600 116.600 207.800 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008576 0.004952 0.000000 0.00000 SCALE2 0.000000 0.009903 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004812 0.00000